Pulmonx (LUNG) Accumulated Expenses (2019 - 2025)

Pulmonx (LUNG) has 7 years of Accumulated Expenses data on file, last reported at $14.6 million in Q4 2025.

• On a quarterly basis, Accumulated Expenses fell 11.63% year-over-year to $14.6 million in Q4 2025; TTM through Dec 2025 was $14.6 million, a 11.63% decrease from a year earlier, with the FY2025 full-year figure at $14.6 million, down 11.63% from the prior year.
• Accumulated Expenses for Q4 2025 stood at $14.6 million, down from $14.9 million in the prior quarter.
• Over the last five years, Accumulated Expenses for LUNG reached as high as $16.5 million in Q4 2024 and fell as low as $9.8 million in Q1 2021.
• Historically, Accumulated Expenses has averaged $12.7 million across 5 years, with a median of $12.6 million in 2021.
• Across the five-year window, Accumulated Expenses soared 54.5% in 2021 and retreated 13.17% in 2022, its largest moves.
• Year by year, Accumulated Expenses stood at $13.4 million in 2021, then dropped by 0.67% to $13.3 million in 2022, then advanced by 22.28% to $16.2 million in 2023, then rose by 1.47% to $16.5 million in 2024, then declined by 11.63% to $14.6 million in 2025.
• Per Business Quant data, the three most recent Accumulated Expenses figures were $14.6 million in Q4 2025, $14.9 million in Q3 2025, and $14.4 million in Q2 2025.